Korean Shares Rise on Tech, Pharma Strength
2026-02-24 02:04
By
Mariene Camarillo
1 min. read
The benchmark KOSPI climbed 2.11% to close at 5,969 on Tuesday, extending gains to a record high as strong technology and pharmaceutical sector performance lifted sentiment.
Notable contributions came from semiconductor stocks, Samsung Electronics (+0.47%) and SK Hynix (+0.63%), while pharmaceutical firms led sector gains, including Celltrion (+2.78%) and Samsung Biologics (+0.87%).
Optimism was further supported by robust economic data, as South Korea’s business sentiment turned positive for March, with the business survey index at 102.7.
Meanwhile, producer prices rose for a fifth consecutive month in January, with the PPI up 1.9% year-on-year.
On the other hand, uncertainty increased after the US Supreme Court ruling on reciprocal tariffs, as the Trump administration quickly imposed a global 10% surcharge, which allows for levies of up to 15% for 150 days.